Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...

"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.

More patients in FMD group met primary outcome of clinical response and prespecified secondary outcome of clinical remission.

Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets, which can be taken with or without food. Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia ...

Apple really pulled off a great feat. You can now test your hearing with your AirPods Pro 2 and an iPhone running iOS 18. It’s a groundbreaking feature, FDA-approved and perfect for catching mild to ...

The effectiveness of repurposed medications for treating COVID-19 remains a critical area of investigation. A new analysis found that higher-dose fluvoxamine (Luvox), an antidepressant with ...

A mindfulness-based cognitive therapy self-help (MBCT-SH) intervention in which patients were supported by a trained practitioner led to better clinical outcomes at lower cost than ...

As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...

Under the legislation, a TBI Innovation Grant Program would award up to $30 million in grants through 2028 to non-VA health care providers, among others.

VANCOUVER--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating ...